TUBERCULOSIS (TB)- WHAT IS NEW

Guest Editors: Qian Gao (Shanghai Medical College, Fudan University, China) and Wenhong Zhang (Huashan Hospital, Fudan University, China)

EMI Special Topics - TB focuses on the characterization of TB, a pathogen that continues to create an unacceptable burden of human suffering and loss, which is overwhelmingly borne by poor and vulnerable people living in low- or middle-income countries. Progress in the global control of TB is, however, constrained by the lack of highly effective and widely accessible diagnostics, drugs and vaccines.

The EMI Special Topic-TB incorporates research reports and high quality reviews on the following areas of TB research: epidemiology, fundamental research, development of new diagnostics and biomarkers, development of new drugs and vaccines, and public health issues related to this important pathogen.

More articles to be added soon.

Featured Articles from EMI
Other Featured Articles from Springer Nature
The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?

Anastasia Koch, Valerie Mizrahi and Digby F Warner

Emerg Microbes Infect 3: e17; doi:10.1038/emi.2014.17

Subject Category: Antimicrobials and drug resistance

Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis

Jing Li, Xu Gao, Tao Luo, Jie Wu, Gang Sun, Qingyun Liu, Yuan Jiang, Yangyi Zhang, Jian Mei and Qian Gao

Emerg Microbes Infect 3: e19; doi:10.1038/emi.2014.21

Subject Category: Antimicrobials and drug resistance

The role of biomedical research in global tuberculosis control: gaps and challenges

Christine F Sizemore, Amanda C Schleif, Jessica B Bernstein and Carole A Heilman

Emerg Microbes Infect 1: e9; doi:10.1038/emi.2012.21

Subject Category: Bacteria and bacterial diseases

‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility

Ying Zhang, Kwok Chiu Chang, Chi-Chiu Leung, Wing Wai Yew, Brigitte Gicquel, Dorothy Fallows, Gilla Kaplan, Richard E Chaisson and Wenhong Zhang

Emerg Microbes Infect 1: e5; doi:10.1038/emi.2012.18

Subject Category: Antimicrobials and drug resistance

Tuberculosis vaccine research in China

Douglas B Lowrie

Emerg Microbes Infect 1: e7; doi:10.1038/emi.2012.3

Subject Category: Vaccines

Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis

Shuo Zhang, Jiazhen Chen, Wanliang Shi, Wei Liu, Wenhong Zhang and Ying Zhang

Emerg Microbes Infect 2: e34; doi:10.1038/emi.2013.38

Subject Category: Antimicrobials and drug resistance

Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis

Wanliang Shi, Jiazhen Chen, Jie Feng, Peng Cui, Shuo Zhang, Xinhua Weng, Wenhong Zhang and Ying Zhang

Emerg Microbes Infect 3: e58; doi:10.1038/emi.2014.61

Subject Category: Antimicrobials and drug resistance

Global tuberculosis control: lessons learnt and future prospects

Christian Lienhardt, Philippe Glaziou, Mukund Uplekar, Knut Lönnroth, Haileyesus Getahun & Mario Raviglione

Nature Reviews Microbiology 10, 407-416 (May 2012) | doi:10.1038/nrmicro2797

The challenge of new drug discovery for tuberculosis

Anil Koul, Eric Arnoult, Nacer Lounis, Jerome Guillemont & Koen Andries

Nature 469, 483-490 (January 2011) | doi:10.1038/nature09657